Healthcare BPO Market is Projected to Reach USD 468.5 Billion. Here’s What America is Outsourcing

Healthcare BPO Market is segmented By Type – Healthcare Payer BPO, Healthcare Provider BPO, Healthcare Pharmaceutical BPO, Healthcare BPO Market By Application – Research and Development, Manufacturing, Non-Clinical Services. Global Opportunity Analysis and Industry Forecast 2021 – 2027. It is published in Valuates Reports under the Health  Category.

The global Healthcare BPO market size is projected to reach USD 316930 Million by 2027, from USD 178070 Million in 2020, at a CAGR of 8.6% during 2021-2027.

Major Factors Driving The Growth Of The Healthcare BPO Market Are:

The growing outsourcing in the pharmaceutical and biopharmaceutical industries, the need to contain rising healthcare costs, rising demand for niche services (such as care management and fraud detection services), and the need for structured processes and documentation in the healthcare industry are all contributing to the healthcare BPO market growth.

The rise of nearshore outsourcing destinations and access to technology is also a major driving factor for the healthcare BPO market. Companies have started outsourcing their business processes to BPO service providers in the same region since nearshore gives them the advantage of cultural, time zone, and language similarities, which helps them produce better-quality services.

Increased government support through investments and the provision of higher-quality treatment techniques are likely to boost the healthcare BPO market’s growth prospects. In addition, the availability of qualified operators in customer care services has a substantial impact on the global healthcare BPO market demand.

Get Your Sample Today: https://reports.valuates.com/request/sample/QYRE-Auto-7K2492/Healthcare_BPO_Market

TRENDS INFLUENCING THE GROWTH OF THE HEALTHCARE BPO MARKET

Increasing nearshore outsourcing is expected to drive the growth of healthcare BPO. Companies have started outsourcing their business processes to BPO service providers in the same region since nearshoring gives them the advantage of cultural, time zone, and linguistic similarities, which helps them produce better-quality services. Companies have also begun to focus on protecting their outsourced operations and limiting socio-economic risks through similar currency and regulatory regimes, which might help accelerate the growth of nearshore outsourcing destinations and technology access.

Increasing pressure to reduce the rising healthcare costs is expected to further augment the Healthcare BPO market. Outsourcing allows organizations to save money on resource management, labor, and space, all of which are key considerations. The emergence of health insurance exchanges (online marketplaces for purchasing health insurance from competing providers) in the United States is putting pressure on healthcare payers’ margins. This allows consumers to acquire coverage from competing private healthcare providers, which is expected to accelerate the adoption of outsourcing as a cost-cutting strategy. As a result, rising healthcare costs are likely to promote offshore outsourcing and, as a result, the global healthcare BPO industry.

Cloud-based BPO has transformed business outsourcing operations, assisting healthcare firms in lowering costs, developing global delivery models, and ensuring safe data access. Cloud-based BPO services are expected to become more popular in the future, and in turn, are expected to provide lucrative growth opportunities for the healthcare BPO market players during the forecast period.

Browse The Table Of Contents And List Of Figures At https://reports.valuates.com/reports/QYRE-Auto-7K2492/global-healthcare-bpo

Healthcare BPO Market Share Analysis:

Based on region, North America is expected to be the most lucrative during the forecast period. The growth of the healthcare BPO market in North America is being driven by factors such as rising demand to decrease costs and improve services, as well as changing regulatory restrictions.

Based on application, the research and development segment is expected to be the most lucrative during the forecast period. Increasing research and development activities with the growing prevalence of introducing quality drugs or vaccines are propelling the demand of this segment.

Healthcare BPO Market By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Inquire For Customization: https://reports.valuates.com/request/customisation/QYRE-Auto-7K2492/Healthcare_BPO_Market

Healthcare BPO Market By Company

  • Quintiles
  • HCL
  • Cognizant
  • Covance
  • Accenture
  • Inventiv
  • Catalent
  • Parexel
  • Lonza
  • Boehringer Ingelheim
  • Charles Rivers
  • Genpact
  • Sutherland
  • PremierBPO
  • Firstsource
  • PPD
  • GeBBS Healthcare
  • Indian Healthcare BPO

Inquire For Chapter Cost: https://reports.valuates.com/request/chaptercost/QYRE-Auto-7K2492/Healthcare_BPO_Market

Buy Now for Single User + Covid-19 Impact : https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-7K2492&lic=single-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS :

–  The global Life Sciences BPO market size is projected to reach USD 243320 million by 2027, from USD 149550 million in 2020, at a CAGR of 7.1% during 2021-2027.

–  The global Customer Care BPO market size is projected to reach USD 81040 million by 2027, from USD 53950 million in 2020, at a CAGR of 6.0% during 2021-2027.

–  The global Healthcare Provider Network Management market size is projected to reach USD 3696 million by 2027, from USD 2373 million in 2020, at a CAGR of 6.1% during 2021-2027.

–  The global Business Process Outsourcing (BPO) market size is projected to reach USD 241370 million by 2027, from USD 180440 million in 2020, at a CAGR of 4.2% during 2021-2027.

–  The global BPO Business Analytics market size is projected to reach USD 174480 million by 2027, from USD 113510 million in 2020, at a CAGR of 6.3% during 2021-2027.

–  The global healthcare payer services market was valued at USD 19,409.52 million in 2019, and is projected to reach USD 41,906.64 million by 2027, registering a CAGR of 10.6% from 2020 to 2027.

–  The global Contract Research Organization (CRO) market size is projected to reach USD 124230 million by 2027, from USD 58000 million in 2020, at a CAGR of 11.4% during 2021-2027.d

–  Global Healthcare Supply Chain BPO Market Size, Status and Forecast 2021-2027

–  Global Cloud Business Process Outsourcing (BPO) Market Size, Status and Forecast 2021-2027

–  Global Insurance Business Process Outsourcing (BPO) Market Size, Status and Forecast 2021-2027

–  Global IT and BPO Services Market Size, Status and Forecast 2021-2027

Click Here To See Related Reports on Healthcare BPO

About Us:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that’s why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

Contact Us:

Valuates Reports
sales@valuates.com

For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter – https://twitter.com/valuatesreports
LinkedIn – https://in.linkedin.com/company/valuatesreports

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”